Article
Author(s):
London-Routine testing for color vision deficiency is not a reliable method to detect digoxin toxicity in patients taking the drug for heart failure or other cardiac problems, said J.G. Lawrenson, PhD.
Economic burden of late-stage age-related macular degeneration
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Prevent Blindness declares April as Women’s Eye Health and Safety Month
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Opthea discontinues COAST and ShORe trials in wet AMD
Study: No significant long-term benefits found in cocoa extract for AMD